Kupando GmbH

https://www.kupando.com

Kupando is a pioneering biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases. The Company uses its small molecule-based drug candidates to build a pipeline in several indications, in-house or via strategic partnerships, as single agent, or in combination with checkpoint inhibitors, other drugs or antigens. Its drug candidate KUP101 is the only TLR 4/7 agonist in development and consists of two small molecules, TLR4 agonist and TLR7 agonist, co-encapsulated. IND-enabling work is on-going for treatment of solid tumors and prophylaxis of infectious diseases. Kupando is a private company, seed financed by its CEO Johanna Holldack and based on technology invented by Dennis Carson’s Laboratory at the University of California San Diego. The Company’s management team brings a unique wealth of experience in business and drug development, gained in the US and Europe. Kupando is headquartered in Schoenefeld, Germany. *

	Start	2021-11-25 established
	Industry	TLR agonist
	Industry 2	drug development
	Person	Holldack, Johanna (Kupando 202209– CEO + Founder before TreThera + Avaris + Telormedix + Borean Pharma + MediGene)
	Person 2	Leppert, Angelika (Kupando 202209 CFO before Bavaria (govt) 202004 Start-up Coach, Strategy + Corporate Finance)

	Street	2 Willy-Brandt-Platz
	City	12529 Schönefeld
	Tel	+49-30-5200586020
		Address record changed: 2022-09-26

Basic data	Employees	n. a.

		* Document for »About Section«: Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld.

		Record changed: 2023-12-30

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Kupando GmbH

[1] Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)